Accepted Manuscripts                   Back to the articles list | Back to browse issues page

XML Print


Abstract:   (56 Views)
Introduction: Diabetic neuropathy is a common complication of diabetes mellitus. It is associated to nerve damage due to oxidative stress and high levels of pro-inflammatory mediators. In the present study, we examined the anti-nociceptive effects of Fullerene nanoparticle, as a potent anti-oxidant, during diabetic neuropathy.
Methods: Diabetes mellitus induced through injection of stereptozotocin (STZ) (40 mg/kg). Four groups used in the study as follows: the control, control+fullerene, diabetes, and diabetes mellitus+fullerene groups. All four groups received sesame oil. Treatment rats received fullerene C60 (1mg/kg/day) for 9 weeks by intra-gastric gavage. Then, cold allodynia, histology and tumor necrosis factor-α (TNF- α) protein expression of the hippocampus measured on 9 weeks after injection of STZ.
Results: Our data revealed that STZ induces cold allodynia in both hind paw and increases the TNF- α protein expression in the hippocampus. Furthermore, STZ induces neural degeneration of hippocampus. Additionally, fullerene C60 significantly attenuated cold allodynia and TNF- α protein expression. Also, fullerene C60 have neuro-protective effects on hippocampal neurons. However, fullerene C60 did not significantly reduce serum glucose level in diabetic animals.
Conclusion: Our data suggest that fullerene C60 likely suppressed pain, and neural loss of hippocampus by inhibitory effects on TNF- α protein expression in the hippocampus during diabetes.
     
Types of Manuscript: Original Research | Subject: Diabetes

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.